scorecardresearch
Add as a preferred source on Google
Saturday, December 20, 2025
TopicSerum Institute India

Topic: Serum Institute India

How Serum Institute, DNDi tie-up for affordable antibody will bolster global fight against dengue

There is no specific medicine for dengue yet. If ongoing Phase III trials yield positive results, an effective, affordable & specific antiviral would be available, 'ultimately saving more lives'. 

Karan Johar’s studio sells 50% stake worth 10 bn rupees to vaccine maker Adar Poonawalla

SII CEO will buy stake through his production company, Serene Productions -- another major investment outside pharma sector after picking up 20% of social media platform Wakau Interactive in 2021.

Serum Institute to double investment in Biocon’s unit to $300 million

Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said.

Rising Covid cases in China concerning but India need not panic, says SII CEO Aadar Poonawalla

The Serum Institute CEO’s tweet came a day after the Health Ministry urged states to ramp up the genome sequencing of positive samples to keep track of newer Covid variants.

Covid on the wane, Serum Institute eyes November launch for India’s first cervical cancer shot

HPV responsible for 95% of all cervical cancer. National Technical Advisory Group on Immunisation recommended HPV vaccine's inclusion in India's Universal Immunisation Programme in 2017.

Serum Institute plans to launch Covid vaccine for children in next 6 months

Speaking at a conference Tuesday, Serum Institute of India's CEO Adar Poonawalla said the Covovax vaccine is under trial & would offer protection to children as young as 3 years.

Not in favour of mixing two Covid vaccines for better efficacy, says Cyrus Poonawalla

If cocktail vaccines are administered and if the result is not good, then SII may say that another vaccine was not good or vice versa, Poonawalla added.

DCGI grants permission to Serum Institute to manufacture Sputnik V in India

The permission has been granted for examination, test and analysis of the Sputnik vaccine at SII's licensed Hadapsar facility under certain conditions, official sources said.

Serum Institute says executive’s remarks on Covid vaccination drive is ‘not company’s view’

Suresh Jadav, executive director, Serum Institute, alleged Friday that the govt began vaccinating people without taking into account available stock of vaccines and WHO guidelines.

On Camera

Henry George’s Single Tax offers a democratic alternative to communist remedies: DM Kulkarni

The immediate benefit of Single Tax would be to reduce the sale prices of land to nominal ones. Landowners would no longer find it profitable to keep idle lands, wrote DM Kulkarni in 1960.

China is taking India to WTO over subsidies, again. Here’s what it’s arguing before trade body

Dispute will now move to consultative process, which allows the two sides to come to an amicable agreement within 60 days.

Israel has ‘realised who its real friend is’, eyes defence expansion in India amid arms curbs by others

It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.

Dhurandhar shows hard cinema is soft power and Pakistan is unapologetically the target

If Pathaan gave both conservatives and liberals room to hide, Dhurandhar extends no such courtesy. Aditya Dhar ripped open that tent of hypocrisy and turned the knife.